Provided by Tiger Trade Technology Pte. Ltd.

Cohen & Steers

83.16
+1.742.14%
Pre-market: 83.340.1800+0.22%05:46 EDT
Volume:287.76K
Turnover:23.82M
Market Cap:4.27B
PE:25.58
High:83.56
Open:81.99
Low:79.55
Close:81.42
52wk High:86.56
52wk Low:58.39
Shares:51.39M
Float Shares:27.75M
Volume Ratio:1.22
T/O Rate:1.04%
Dividend:2.58
Dividend Rate:3.10%
EPS(TTM):3.25
EPS(LYR):2.97
ROE:27.33%
ROA:14.54%
PB:7.25
PE(LYR):28.00

Loading ...

Cohen & Steers RQI Fund Pays June Distribution of $0.09 Per Share

Reuters
·
Jun 30

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies

GlobeNewswire
·
Jun 30

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

GlobeNewswire
·
Jun 30

TEMC CNS Wins KRW25.3 Billion Deal for Chemical Supply Equipment from SK Hynix

MT Newswires Live
·
Jun 26

Press Release: Maplight Therapeutics Announces Changes to Board of Directors

Dow Jones
·
Jun 24

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone

GlobeNewswire
·
Jun 23

Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial

GlobeNewswire
·
Jun 23

CIBC Asset Management adds Cohen & Steers, Maple-Brown Abbott as sub-advisers to CIBC Private Real Assets Mandate

Reuters
·
Jun 23

Press Release: Cohen & Steers Closed-End Funds Declare Distributions for July, August and September 2026

Dow Jones
·
Jun 23

Press Release: Dyne Therapeutics Appoints Barry Greene to Board of Directors

Dow Jones
·
Jun 23

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants

GlobeNewswire
·
Jun 22

LG CNS, Doosan Sign Deal for AI, Robotics, Data Center Business Collabs

MT Newswires Live
·
Jun 19

Solvonis Wins Shareholder Backing as It Advances CNS Drug Pipeline

TIPRANKS
·
Jun 19

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 19

Denali Monetizes FDA Voucher to Advance CNS Pipeline

TIPRANKS
·
Jun 18

Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire
·
Jun 18

Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators

GlobeNewswire
·
Jun 18

Press Release: Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.

Dow Jones
·
Jun 17

Top Executive Makes Notable Insider Move at Cohen & Steers

TIPRANKS
·
Jun 17

Cohen & Steers EVP Daniel Noonan disposes of USD 615,595 in common shares

Reuters
·
Jun 17